Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
1987-6-26
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0300-2977
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
85-93
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:3035391-Antineoplastic Agents,
pubmed-meshheading:3035391-Carcinoma, Small Cell,
pubmed-meshheading:3035391-Doxorubicin,
pubmed-meshheading:3035391-Drug Resistance,
pubmed-meshheading:3035391-Humans,
pubmed-meshheading:3035391-Lung Neoplasms,
pubmed-meshheading:3035391-Methotrexate
|
pubmed:year |
1987
|
pubmed:articleTitle |
Drug resistance in medical oncology.
|
pubmed:publicationType |
Journal Article,
Review
|